Markets
Fridays for Future - Hanover
A poster that reads "Game over?" with a Pac-Man eating the earth (Christophe Gateau/Getty Images)
EATING THE WORLD

Meet the new AI winners as investors flip from semiconductors to software

Chip demand ex-AI is faltering, and AI-enabled software is in ascendance. Crypto’s helping, too.

Luke Kawa
12/4/24 1:15PM

Software is back to eating the world — with a big assist from crypto.

The tech-heavy Nasdaq 100 has marginally outperformed the S&P 500 since the US election, even as semiconductor stocks have barely been treading water.

The new leaders in tech? The software stocks that were largely abandoned as investors focused on utilities and semiconductors — pockets of the market most sensitive to the AI build-out and associated demand for electricity.

The sweepy top-down story for this changing of the guard looks something like this:

Worries that semiconductor spending would crowd out demand for software amid the AI boom proved overblown. Not only that, but the investable artificial-intelligence theme itself has shifted downstream, with AI-enabled software companies like AppLovin and Palantir posting massive gains and flows no longer favoring the so-called Magnificent 7 stocks. Meanwhile, we’re living in a world of extreme bifurcation within the semi space, where spending on top-of-the-line chips from Nvidia used to power the AI boom is still strong (though slowing), while demand ex-AI has been moribund

A smattering of examples over the past few months: 

Another subplot of the return of software supremacy, however, is that it’s also crypto in drag.

Two of the top three stocks in the iShares Expanded Tech Software ETF since the US election have been MicroStrategy (levered bitcoin buyer) and Marathon Digital (bitcoin miner that’s now also aping the Saylor strategy), with both up more than 50% over this period. 

More Markets

See all Markets
markets
Luke Kawa
9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.